Bio Protocol vs Nomina — how do they compare? Bio Protocol trades at Rp440.06 (market cap Rp998,02M, Rp177,99M 24h volume), while Nomina trades at Rp26.96 (market cap Rp78,14M, Rp57,21M 24h volume). The key difference: Bio Protocol is far larger — about 12.8× Nomina's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 2,9B / 7,5B NOM (39%) for Nomina. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Nomina for 22 Days on average.
| BIO | NOM | |
|---|---|---|
Market Cap | Rp998,02M | Rp78,14M |
Volume (24h) | Rp177,99M | Rp57,21M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 2,9B / 7,5B NOM (39%) |
Typical Hold Time | 18 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Nomina (NOM) is trading at Rp28,216 with a market cap of Rp81.42 million, exhibiting a bullish technical signal supported by moving averages. The asset shows neutral oscillators and key support at Rp28. With 39% of its max supply in circulation and a 22-day average hold time, on-chain activity indicates moderate distribution. No major protocol updates or ecosystem news were identified recently.
Overall outlook is cautiously optimistic due to bullish technicals, but low market cap and liquidity pose significant risks. Key opportunities include potential growth from increased adoption, while major risks involve high volatility and limited exchange depth. Investors should monitor for any ecosystem developments or regulatory changes.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Nomina is a rebranded DeFi platform designed to simplify advanced trading strategies and cross-exchange operations in perpetual futures markets. Evolving from Omni Network through a 1:75 token swap, Nomina streamlines complex DeFi trading with automation and unified tools. Built for experienced traders, it enhances efficiency and accessibility across decentralized exchanges, offering a more seamless and intelligent trading experience.
Read more on NOM →